Search NLS News

IRLAB Therapeutics has announced that dosing has been initiated in a Phase I clinical study of the drug candidate IRL757 in healthy adults aged 65 and older.

The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2024 to David Baker “for computational protein design” and Demis Hassabis and John M. Jumper “for protein structure prediction”.

The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Physics 2024 to John J. Hopfield, Princeton University, NJ, USA, and Geoffrey E. Hinton, University of Toronto, Canada.

The MedDev Day conference in Copenhagen brought together industry leaders and experts to discuss pivotal developments in medical device legislation.

Lithuanian company Celltechna has opened the first and only gene therapy centre in the Baltic States in Vilnius, Lithuania.

NordicRWE is the first Norwegian company to join the AstraZeneca BioVentureHub at the Gothenburg R&D site.

AstraZeneca has entered into an exclusive license agreement with CSPC Pharmaceutical Group to advance the development of an early stage, novel small molecule Lipoprotein (a) (Lp(a)) disruptor that has the potential to offer additional benefits for patients with dyslipidaemia.

Victor Ambros and Gary Ruvkun discovered microRNA, a new class of tiny RNA molecules that play a crucial role in gene regulation.

Caroline Leksell Cooke has global experience in the software sector, with various positions in Google and, most recently, founded her own company focusing on digital transformation.

The two companies have expanded their partnership to accelerate the development of the Dispersome technology platform and further expand its applicability and reach for increasing the solubility and bioavailability of small drug molecules.